Summary & Overview
HCPCS J7100: Infusion, Dextran 40, 500 ml
HCPCS Level II code J7100 designates the infusion of dextran 40 in a 500 ml vial, a plasma volume expander used in acute volume management and certain perioperative or critical care scenarios. Nationally, accurate coding for intravenous fluids like dextran 40 matters for claims processing, clinical documentation, and supply utilization reporting because these products are administered across hospital inpatient and outpatient infusion settings. Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise clinical and billing context for J7100, including typical sites of service and the clinical purpose of the product. The publication provides benchmarking and reimbursement context where available, summarizes relevant payer coverage considerations, and outlines common billing modifiers and claim-line practices relevant to infusion products. It also highlights policy or coding update considerations and links to related service-line implications. Data not available in the input will be noted where applicable.
Billing Code Overview
HCPCS Level II code J7100 represents infusion of dextran 40, 500 ml. This code describes the administration of a dextran 40 solution in a 500 milliliter volume, typically used as a plasma volume expander or for intravascular volume support.
Service Type: Intravenous infusion
Typical Site of Service: Hospital outpatient infusion suite, inpatient hospital, or other infusion center settings
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A patient receiving J7100 (infusion of dextran 40, 500 ml) is typically an adult in an acute care or outpatient infusion setting who requires plasma volume expansion or intravascular volume support. A realistic scenario: a 68-year-old patient presents to the hospital with symptomatic hypotension after gastrointestinal bleeding. After initial resuscitation with crystalloids and assessment of ongoing blood loss, the treating team administers J7100 to expand intravascular volume while blood products are arranged. The infusion is prepared by pharmacy or the infusion suite and delivered via peripheral or central intravenous access by a registered nurse under physician or advanced practice provider order. Typical workflow steps: patient assessment and vital signs; review of allergies and prior reactions to colloids; IV access verification and appropriate monitoring (vital signs, intake/output, hemodynamic parameters); administration of J7100 per manufacturer dosing and infusion rate with documentation of volume infused and patient response; post-infusion monitoring for signs of hypersensitivity, volume overload, or coagulopathy; billing using J7100 with applicable modifiers and diagnosis linkage. Typical site of service: inpatient hospital ward, emergency department, observation unit, or outpatient infusion center. Typical patient population: adults with hypovolemia from hemorrhage, sepsis-related capillary leak when crystalloids are insufficient, or perioperative volume support when colloid is specifically indicated. Contraindications and caution include severe renal impairment, known hypersensitivity to dextran, or risk of volume overload.
Coding Specifications
| Modifier | Description |
|---|